Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults.
Cummings JF, Polhemus ME, Kester KE, Ockenhouse CF, Gasser RA Jr, Coyne P, Wortmann G, Nielsen RK, Schaecher K, Holland CA, Krzych U, Tornieporth N, Soisson LA, Angov E, Heppner DG; RTS,S Vaccine Evaluation Group. Cummings JF, et al. Among authors: tornieporth n. Vaccine. 2024 Apr 30;42(12):3066-3074. doi: 10.1016/j.vaccine.2024.03.072. Epub 2024 Apr 6. Vaccine. 2024. PMID: 38584058 Free article. Clinical Trial.
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Voss G, Jacquet JM, Tornieporth N, Kampmann B, Karron R, Meulen AS, Chen R, Gruber M, Lurie N, Weller C, Cramer JP, Saville M, Darko M. Voss G, et al. Among authors: tornieporth n. Vaccine. 2021 Dec 17;39(51):7357-7362. doi: 10.1016/j.vaccine.2021.10.048. Epub 2021 Nov 17. Vaccine. 2021. PMID: 34799142 Free PMC article.
Medical countermeasures against henipaviruses: a review and public health perspective.
Gómez Román R, Tornieporth N, Cherian NG, Shurtleff AC, L'Azou Jackson M, Yeskey D, Hacker A, Mungai E, Le TT. Gómez Román R, et al. Among authors: tornieporth n. Lancet Infect Dis. 2022 Jan;22(1):e13-e27. doi: 10.1016/S1473-3099(21)00400-X. Epub 2021 Nov 1. Lancet Infect Dis. 2022. PMID: 34735799 Free PMC article. Review.
A review of Lassa fever vaccine candidates.
Salami K, Gouglas D, Schmaljohn C, Saville M, Tornieporth N. Salami K, et al. Among authors: tornieporth n. Curr Opin Virol. 2019 Aug;37:105-111. doi: 10.1016/j.coviro.2019.07.006. Epub 2019 Aug 28. Curr Opin Virol. 2019. PMID: 31472333 Review.
WHO preferred product characteristics for new vaccines against tuberculosis.
Schrager LK, Chandrasekaran P, Fritzell BH, Hatherill M, Lambert PH, McShane H, Tornieporth N, Vekemans J. Schrager LK, et al. Among authors: tornieporth n. Lancet Infect Dis. 2018 Aug;18(8):828-829. doi: 10.1016/S1473-3099(18)30421-3. Lancet Infect Dis. 2018. PMID: 30064668 No abstract available.
Symptomatic Dengue in Children in 10 Asian and Latin American Countries.
L'Azou M, Moureau A, Sarti E, Nealon J, Zambrano B, Wartel TA, Villar L, Capeding MR, Ochiai RL; CYD14 Primary Study Group; CYD15 Primary Study Group. L'Azou M, et al. N Engl J Med. 2016 Mar 24;374(12):1155-66. doi: 10.1056/NEJMoa1503877. N Engl J Med. 2016. PMID: 27007959 Free article.
62 results